PRESS RELEASE published on 06/13/2025 at 08:30, 7 months 10 days ago Transgene to Participate in Upcoming Meetings with Biotech Industry Leaders Transgene to participate in upcoming meetings with biotech industry leaders to discuss positive clinical data on neoantigen cancer vaccine TG4050 and present innovative immunotherapies. Learn more at www.transgene.com Biotech Industry Clinical Data Transgene Immunothérapies Neoantigen Cancer Vaccine
PRESS RELEASE published on 06/13/2025 at 08:00, 7 months 10 days ago Transaction in Own Shares Molten Ventures plc (LSE: GROW) announces purchase of 70,000 Ordinary Shares at prices ranging from 294.40p to 310.00p per share on 12 June 2025. Share capital details provided Share Repurchase Ordinary Shares Molten Ventures Plc Numis Securities LSE: GROW
PRESS RELEASE published on 06/13/2025 at 07:30, 7 months 10 days ago Inside Information / Other news releases MaaT Pharma presents updated positive data for Xervyteg® in treating acute Graft-versus-Host Disease at EHA Congress, validating high efficacy observed in pivotal ARES study MaaT Pharma Acute Graft-versus-Host Disease EMA Approval Xervyteg EAP Data
PRESS RELEASE published on 06/13/2025 at 07:00, 7 months 10 days ago Inside Information / Other news releases Innate Pharma highlights preclinical antitumor activity of IPH6501 in DLBCL and FL at the 2025 EHA Congress, presenting potent efficacy in in vitro and in vivo models with R-CHOP combination Preclinical Data EHA Congress Innate Pharma Antitumor Activity IPH6501
PRESS RELEASE published on 06/13/2025 at 06:57, 7 months 10 days ago Adjustment of the Conversion Price for the convertible bond of LEG Immobilien SE in the amount of EUR 400 million due on September 1, 2025 (ISIN DE000A2GSDH2) LEG Immobilien SE adjusts Conversion Price for EUR 400 million convertible bond due on Sep 1, 2025, following dividend payments. Conversion Price now EUR 112.9577 Financial Year 2024 Convertible Bond Conversion Price LEG Immobilien SE Dividend Adjustment
PRESS RELEASE published on 06/13/2025 at 06:30, 7 months 10 days ago Merger of Helvetica Swiss Commercial Fund and Helvetica Swiss Opportunity Fund: notification of conversion ratio Merger of Helvetica Swiss Commercial Fund and Helvetica Swiss Opportunity Fund scheduled for 20 June 2025 with notification of conversion ratio and NAV per share details Merger Commercial Property Helvetica Property Fund Conversion Ratio
PRESS RELEASE published on 06/13/2025 at 05:45, 7 months 10 days ago HKSTP Delegation Debut at VivaTech 2025 Paris HKSTP leads Hong Kong innovators to VivaTech 2025 in Paris to enhance global tech development. Key partnerships and awards showcased Innovation HKSTP Partnerships VivaTech 2025 Global Tech
PRESS RELEASE published on 06/13/2025 at 02:35, 7 months 10 days ago Northern Dynasty: Pebble Partnership Consents to EPA Request for Additional 20-day Abeyance to July 3, 2025 Northern Dynasty Minerals Ltd. and its subsidiary Pebble Limited Partnership have agreed to a 20-day abeyance in litigation with the EPA and USACE. The company aims to accelerate copper production in Alaska and the U.S Northern Dynasty Minerals Ltd. Litigation EPA Pebble Limited Partnership USACE
PRESS RELEASE published on 06/13/2025 at 01:25, 7 months 10 days ago Moderna Receives U.S. FDA Approval for RSV Vaccine, mRESVIA, in Adults Aged 18–59 at Increased Risk for RSV Disease Moderna receives FDA approval to expand indication of mRESVIA vaccine for adults aged 18-59 at increased risk of RSV, based on Phase 3 study results showing safety and efficacy FDA Approval Moderna RSV Vaccine Phase 3 Study MRESVIA
PRESS RELEASE published on 06/13/2025 at 01:15, 7 months 10 days ago IEH Corporation Files Form 10-K for Fiscal Year Ended March 31, 2025 IEH Corporation (OTC PINK:IEHC) reports strong financial results for FY 2025, including a 34% revenue increase and significant profit improvements. CEO Dave Offerman highlights positive outlook Financial Results Revenue Increase Profit Improvements IEH Corporation CEO Dave Offerman
Published on 01/23/2026 at 22:01, 37 minutes ago Zomedica Expands its TRUVIEW(R) Microscopy Platform with AI Diagnostic Interpretation, Growing its Market Opportunity
Published on 01/23/2026 at 16:40, 5 hours 58 minutes ago Excalibur IP Survey Results Confirm High Priority Copper Gold Drill Targets
Published on 01/23/2026 at 15:15, 7 hours 23 minutes ago RETRANSMISSION: Amarc and Freeport Continue Expanding High Grade Aurora Copper-Gold-Silver Deposit
Published on 01/23/2026 at 15:00, 7 hours 38 minutes ago Vox Royalty Transfers Brazil-Linked Offtake To Greenstone Gold Mine
Published on 01/23/2026 at 14:00, 8 hours 38 minutes ago Dateline Resources Completes $35M Institutional Placement to Expand Drilling and Advance Colosseum Towards Production
Published on 01/23/2026 at 21:21, 1 hour 17 minutes ago EQS-Adhoc: LR Health & Beauty SE: PRELIMINARY RESULTS FOR FINANCIAL YEAR 2025 / TARGETED EQUITY CONTRIBUTION / TARGETED RESTRUCTURING OF THE 2024/2028 BONDS
Published on 01/23/2026 at 19:42, 2 hours 56 minutes ago EQS-Adhoc: ABO Energy GmbH & Co. KGaA concludes standstill agreement with creditors of significant financing arrangements
Published on 01/23/2026 at 19:02, 3 hours 36 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 01/23/2026 at 18:50, 3 hours 48 minutes ago Mercedes-AMG PETRONAS F1 Team Announces Collaboration Agreement with Zuma
Published on 01/23/2026 at 15:45, 6 hours 53 minutes ago Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc.
Published on 01/22/2026 at 17:40, 1 day 4 hours ago Disclosure of shares outstanding and voting rights - 22.01.2026
Published on 01/22/2026 at 08:45, 1 day 13 hours ago Air Liquide voluntary low-carbon electricity sourcing gains momentum, with 3 TWh per year of additional PPAs started in 2025
Published on 01/22/2026 at 08:29, 1 day 14 hours ago bioMérieux Acquires Accellix to Elevate Pharmaceutical Quality Control and Accelerate Advanced Therapies